News and events

First patient treated in cutting-edge rare liver disease clinical trial Inflammatory liver disease Oral, intestinal and systemic health

Innovative organ-on-a-chip technology could shed light on cell behaviour in liver cancer Inflammatory liver disease Next generation therapies Back to top

New stromal cell treatment for chronic inflammatory diseases being trialled Inflammatory liver disease Industry Back to top

Birmingham study explores potential target to treat liver disease Inflammatory liver disease Back to top

Bridging science and creativity: a reflective session on liver health Inflammatory liver disease Patient and public involvement Back to top

New research into autoimmune liver condition suggests unique cell movements may be driving disease Inflammatory liver disease Back to top

A milestone achievement: 3,000 patients have joined the NAFLD BioResource Inflammatory liver disease Back to top

Promising target for liver disease treatments identified Inflammatory liver disease Back to top

New inflammatory mechanisms unveiled in the setting of liver disease and liver cancer Inflammatory liver disease Back to top

For the new Midlands Liver Research Alliance, listening comes first Inflammatory liver disease Back to top

ExaLT trial reaches recruitment milestone Inflammatory liver disease Back to top

2000 volunteers for NAFLD BioResource Inflammatory liver disease Back to top